Stimunity's Seed Round

Stimunity raised a round of funding on February 28, 2018. Investors include Portage Biotech.

Stimunity is a Paris-based immuno-oncology company. The firm's lead product is a potent biologic enhancer of the STING pathway that activates the immune system against tumor cells.…

Articles about Stimunity's Seed Round: